Coenzyme Q10 / Ubiquinol
SupplementMedical score and community score are closely aligned. The clinical evidence for heart failure [s4] and fertility [s7, s8] is solid, but is barely reflected in the community, which tends to focus on energy and anti-aging [c1, c2]. Community enthusiasm is more subdued than for other antioxidants, as many users report no subjectively perceptible effects [c2].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
CoQ10 has the strongest evidence base among common supplements for cardiovascular indications: the Q-SYMBIO trial showed a significant mortality reduction in heart failure, and meta-analyses confirm improvements in sperm motility for male infertility. For statin-induced myopathy — the most common reason for supplementation in the community — the evidence is disappointingly inconsistent. Healthy, younger individuals often notice little to nothing; the safety profile is excellent, but Ubiquinol formulations are expensive and their advantage over Ubiquinone in everyday use is not clearly established clinically.
Description
Endogenous coenzyme with central role in mitochondrial ATP production and as a fat-soluble antioxidant; supplementation particularly relevant with statin use, heart failure, and age-related dec...
Coenzyme Q10 (CoQ10) is a fat-soluble, vitamin-like molecule synthesized endogenously in the human body via the mevalonate metabolic pathway [s1]. It exists in two biologically active forms: the oxidized form ubiquinone and the reduced form ubiquinol [s2]. Both forms are continuously interconverted in the body, with ubiquinol representing the dominant form in blood [s2]. CoQ10 concentrations decline with increasing age in various tissues [s3]. Statins (HMG-CoA reductase inhibitors) inhibit the same biosynthetic pathway required for CoQ10 production, thereby reducing plasma levels [s3]. Decreased CoQ10 levels have also been observed in individuals with diabetes mellitus, cancer, and heart failure [s3]. Mean daily dietary intake in Germany is estimated at 3–6 mg per day [s12]. Foods with high CoQ10 content include fatty meat, fish, and nuts; however, these amounts are insufficient for therapeutic effects. The most clinically studied indications are chronic heart failure (Q-SYMBIO trial: 300 mg/day ubiquinone over 2 years, significant reduction in cardiovascular events and all-cause mortality) [s4], migraine prophylaxis, and male infertility [s7, s8]. Evidence for statin-induced myopathy is mixed, with several meta-analyses showing no significant benefit [s5, s6]. Regarding bioavailability, studies show that ubiquinol can achieve higher bioavailability than ubiquinone, particularly with modern formulation technology (oil-based softgels, emulsion systems) [s9, s2].
Legal Status (DE)
In Germany, Austria, and Switzerland, CoQ10 (ubiquinone and ubiquinol) is legally marketable as an over-the-counter dietary supplement (food supplement). EFSA has not yet granted any officially approved health claims for CoQ10 under Regulation (EC) No. 1924/2006 [s11, s12]. The BfR recommends seeking medical advice for daily doses exceeding 100 mg [s12].
Mechanism of Action
CoQ10 fulfills two primary functions in the human body [s1, s2]: 1. Mitochondrial electron transfer and ATP synthesis: CoQ10 is an essential component of the mitochondrial respiratory chain (electron transport chain). It transfers electrons from Complex I (NADH dehydrogenase) and Complex II (succinate dehydrogenase) to Complex III (cytochrome bc1 complex), shuttling between its oxidized (ubiquinone) and reduced (ubiquinol) forms. This process is essential for oxidative phosphorylation and the production of ATP, the cell's primary energy carrier [s1, s2]. 2. Fat-soluble antioxidant: Ubiquinol (the reduced form) acts as a potent fat-soluble antioxidant in cell membranes and lipoproteins. It protects membrane phospholipids and LDL cholesterol from oxidative damage by free radicals and can simultaneously regenerate other antioxidants such as vitamin E [s2, s3]. Biosynthesis and age-dependent decline: CoQ10 is synthesized endogenously via the mevalonate pathway, the same metabolic pathway used for cholesterol biosynthesis. Enzymes encoded by COQ2–COQ9 genes modify the benzoquinone ring through methylation, decarboxylation, and hydroxylation [s13]. Statins inhibit HMG-CoA reductase, a central step in this pathway, thereby also reducing endogenous CoQ10 production [s3]. From age 40 onward, endogenous biosynthesis measurably declines; in cardiac tissue of 80-year-olds, only approximately 50% of peak values remain [s3]. Form-specific pharmacology: Following oral ingestion, ubiquinone is reduced to ubiquinol in the intestinal wall and liver; conversely, ubiquinol can be re-oxidized to ubiquinone after absorption. Since both forms are interconverted in the body, the clinical superiority of ubiquinol over ubiquinone as a supplement remains debated [s9]. However, more recent crossover studies demonstrate higher systemic bioavailability for ubiquinol [s9].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Gastrointestinale Beschwerden (Übelkeit, Magenschmerzen, Durchfall, Appetitlosigkeit) Well documented at doses of 100–300 mg/day and generally mild; can be reduced by taking with meals [s10]. | gelegentlich | leicht |
| Kopfschmerzen Occasionally reported at higher doses; usually transient and dose-dependent [s10]. | gelegentlich | leicht |
| Schlaflosigkeit / Schlafstörungen Occasionally reported with evening intake, presumably due to energizing effects on mitochondria; morning or midday intake recommended [s10]. | selten | leicht |
| Erhöhte Müdigkeit / Erschöpfung Paradoxically reported by a minority of users; exact cause unclear [s10, c1]. | selten | leicht |
| Leichte Blutdrucksenkung CoQ10 may mildly lower blood pressure; caution is advised in individuals on antihypertensive medication [s10]. | selten | leicht |
Contraindications
CoQ10 may share structural similarity with vitamin K and attenuate the anticoagulant effect of warfarin and phenprocoumon, potentially increasing thrombotic risk. INR monitoring is mandatory with concomitant use [s10, s16].
Insufficient safety data for pregnancy and lactation; use should only occur with a clear medical indication [s10].
Theoretical risk that CoQ10, as an antioxidant, may reduce the efficacy of certain oxidative chemotherapeutic agents. Consultation with an oncologist is required [s10].
In genetically determined primary deficiency, very high doses (1,200–3,000 mg/day) are required; standard dosing may be insufficient. Mandatory under specialized medical supervision [s15].
Interactions
Synergistic
Ubiquinol can regenerate oxidized vitamin E; synergistic antioxidant effect in lipid membranes and lipoproteins has been described [s2].
Both substances support mitochondrial energy production via complementary mechanisms; frequently combined in fertility and energy studies [s7].
Alpha-lipoic acid neutralizes free radicals and helps regenerate other antioxidants such as CoQ10. The combination supports mitochondrial energy production in a complementary manner.
Acetyl-L-carnitine transports fatty acids into mitochondria, while CoQ10 drives the electron transport chain efficiently. This combination is frequently used to support energy and cognitive protection.
PQQ stimulates mitochondrial biogenesis, thereby enhancing the efficiency of CoQ10 and NADH in energy production. The combination is considered well-tolerated and synergistic.
Combined fat-soluble antioxidants from vitamin E and CoQ10 may significantly improve CoQ10 absorption and enhance the protective effect on pericardiac adipose tissue.
Vitamin C can regenerate oxidized CoQ10 (ubiquinone) back to its active form ubiquinol, thereby enhancing antioxidant protection. The combination of both antioxidants acts synergistically in aqueous and lipophilic compartments.
Like CoQ10, glutathione belongs to the "5 major antioxidants" and acts complementarily in cellular redox homeostasis. Both substances can mutually regenerate each other and protect mitochondria from oxidative damage.
Caution
CoQ10 may reduce the efficacy of vitamin K antagonists; regular INR monitoring required, dose adjustment of the anticoagulant may be necessary [s10, s16].
CoQ10 may have blood pressure-lowering effects; additive effect with antihypertensive medications possible, blood pressure monitoring recommended [s10].
Statins reduce endogenous CoQ10 biosynthesis; CoQ10 supplementation is recommended by some physicians as adjunct therapy, however evidence for clinical improvement of statin-induced myopathy is inconsistent [s5, s6].
Theoretical risk of attenuation of oxidative antitumor mechanisms by CoQ10 as an antioxidant; use during chemotherapy only after consultation with an oncologist [s10].
Berberine has cholesterol-lowering effects similar to weak statins and may, like statins, affect endogenous CoQ10 biosynthesis. Combination with CoQ10 may be beneficial to compensate for potential deficiency.
Possible interactions between CoQ10 as an antioxidant and theophylline have been described. A physician should be consulted when taken concomitantly.
Studies
Tier A — High Evidence
Outcome: Muscle pain in statin-induced myopathy
Effect Size: No significant benefit of CoQ10 in statin-associated myopathy
Outcome: Composite cardiovascular events (MACE) and all-cause mortality in heart failure
Effect Size: 43% reduction in MACE, 42% reduction in all-cause mortality (p<0.05) with ubiquinone 300 mg/day
Outcome: Muscle pain and creatine kinase in statin myopathy
Effect Size: No significant benefit over placebo (WMD not significant)
Outcome: Sperm motility (RR 4.50, 95% CI 3.92–5.08)
Effect Size: Significant increase in motility; concentration RR 5.33 (95% CI 4.18–6.47)
Outcome: Systemic bioavailability of ubiquinol vs. ubiquinone (AUC, Cmax)
Effect Size: Ubiquinol achieved significantly higher systemic bioavailability than ubiquinone
Outcome: Sperm motility, concentration, and semen volume in idiopathic male infertility
Effect Size: Significant increase in total motility (MD: +4.95%; p=0.01); semen volume significantly increased
Tier B — Moderate Evidence
Outcome: Overview of age-dependent CoQ10 decline, statin effects, and disease associations
Effect Size: Consistent evidence for age-dependent decline; clinical implications unclear
Outcome: Migraine frequency and attack duration with adjuvant CoQ10 supplementation
Effect Size: Trend toward fewer migraine attacks per month and shorter attack duration at 100–300 mg/day; pain intensity inconsistent
Tier C — Low Evidence
Outcome: Characterization of the COQ gene family and biosynthesis steps
Effect Size: Mechanistic basis for biosynthesis and deficiencies
Outcome: Dosing in genetically determined primary CoQ10 deficiency
Effect Size: High-dose therapy 1,200–3,000 mg/day for genetic deficiency; prognosis dependent on early detection
Community Evidence
Top reported benefits
- Subtle energy boost and improved stress tolerance
- Reduction of fatigue during statin therapy
- Possible reduction in migraine attacks (individual variation)
- Perceived protection for cardiovascular health in older age
- Improved recovery after intense physical exertion
Top reported issues
- No noticeable effect in healthy, younger individuals
- Occasional paradoxical fatigue after administration
- High price of ubiquinol formulations
- Uncertainty regarding optimal form (ubiquinol vs. ubiquinone)
Many community members report that effects are very subtle or imperceptible, particularly in younger, healthy individuals [c1, c2]. The ubiquinol vs. ubiquinone debate is widespread in the community but without clear consensus [c1, c2, c3]. Individual reports of CoQ10-induced fatigue have been documented [c1]. German forum users discuss product quality and prefer Kaneka ubiquinol as a reference substance [c3, c4].
Scientific Sources
- Coenzyme Q10 - StatPearls
Saini R (2011). StatPearls, NCBI Bookshelf / NIHBLink - Coenzyme Q10 – Side Effects, Precautions, Interactions, Dosing (WebMD / Mayo Clinic)
WebMD Editorial Staff; Mayo Clinic Staff (2024). WebMD Vitamins & Supplements; Mayo Clinic Drugs & SupplementsBLink - Scientific Opinion on the substantiation of health claims related to coenzyme Q10
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010). EFSA JournalADOI - Coenzym Q10: Was ist über gesundheitliche Risiken bekannt – und was nicht?
Bundesinstitut für Risikobewertung (BfR) (2021). BfR (Bundesinstitut für Risikobewertung)ALink - Metabolic Targets of Coenzyme Q10 in Mitochondria
Acosta Lopez MJ, Trevisson E, Vazquez-Fonseca L, et al. (2021). Antioxidants (PMC)BLink - CoQ10 erklärt: Ubichinon vs. Ubichinol – Unterschiede, Wirkung und Vorteile (Migräne-Abschnitt)
NordicOil Redaktion (2024). NordicOil Blog (DACH)CLink - Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain
Rodríguez-Cuenca S, Bhanu NV, Alber J, et al. (2020). International Journal of Molecular Sciences (PMC)BLink - Interaction between warfarin and coenzyme Q10
Landbo C, Almdal TP (1998). Ugeskrift for Laeger (PubMed)CPMID:9621803 - Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine: a meta-analysis
Sazali S, Badrin S, Norhayati MN, Idris NS (2021). BMJ OpenADOI - Coenzyme Q10 - Linus Pauling Institute Micronutrient Information Center
Higdon J, Drake VJ, Delage B (2023). Linus Pauling Institute, Oregon State UniversityBLink - Coenzyme Q10 supplementation – In ageing and disease
Hernandez-Camacho JD, Bernier M, Lopez-Lluch G, et al. (2021). Ageing Research Reviews (ScienceDirect)BDOI - The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial
Mortensen SA, Rosenfeldt F, Kumar A, et al. (2014). JACC: Heart FailureAPMID:25282031DOI - Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials
Qu H, Guo M, Chai H, et al. (2018). Journal of the American Heart AssociationAPMID:30371340DOI - Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis
Banach M, Serban C, Sahebkar A, et al. (2024). PMC / NCBI (systematic review)ALink - Efficacy and Safety of Coenzyme Q10 in Idiopathic Male Infertility: A Systematic Review and Meta-Analysis of Randomized Trials
Kim SW, et al. (2025). World Journal of Men's HealthAPMID:40878114DOI - Coenzyme Q10 and male infertility: a meta-analysis
Lafuente R, González-Comadrán M, Solà I, et al. (2013). Journal of Assisted Reproduction and Genetics / PMCALink - A Randomized, Double-Blind, Two-Treatment, Two-Period, Crossover Study Investigating the Systemic Bioavailability of a Novel Cocrystal Ubiquinol Formulation Compared with a Ubiquinone Formulation in Healthy Adults
Mei X, et al. (2026). Clinical Pharmacology in Drug Development (Wiley)ADOI
Community Sources
Storage
Unopened
Store in a cool, dry, light-protected location; room temperature (15–25 °C) is suitable.
Opened
Keep container tightly closed; protect from moisture and heat; softgels are particularly light-sensitive.
Notes
CoQ10 is sensitive to light and oxidation; oil-based softgel formulations are more stable than powder capsules. Refrigeration can extend stability of ubiquinol-containing products [s2].